Crum CP - Search Results

1

Progress in the management of gynecologic cancer: consensus summary statement.

Cannistra SA, Bast RC Jr, Berek JS, Bookman MA, Crum CP, DePriest PD, Garber JE, Koh WJ, Markman M, McGuire WP 3rd, Rose PG, Rowinsky EK, Rustin GJ, Skates SJ, Vasey PA, King L. Cannistra SA, et al. Among authors: crum cp. J Clin Oncol. 2003 May 15;21(10 Suppl):129s-132s. doi: 10.1200/JCO.2003.04.003. J Clin Oncol. 2003. PMID: 12743127 No abstract available.

2

Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction.

Callahan MJ, Crum CP, Medeiros F, Kindelberger DW, Elvin JA, Garber JE, Feltmate CM, Berkowitz RS, Muto MG. Callahan MJ, et al. Among authors: crum cp. J Clin Oncol. 2007 Sep 1;25(25):3985-90. doi: 10.1200/JCO.2007.12.2622. J Clin Oncol. 2007. PMID: 17761984

3

Epidemiologic correlates of ovarian cortical inclusion cysts (CICs) support a dual precursor pathway to pelvic epithelial cancer.

Folkins AK, Saleemuddin A, Garrett LA, Garber JE, Muto MG, Tworoger SS, Crum CP. Folkins AK, et al. Among authors: crum cp. Gynecol Oncol. 2009 Oct;115(1):108-111. doi: 10.1016/j.ygyno.2009.06.032. Epub 2009 Jul 16. Gynecol Oncol. 2009. PMID: 19615727 Free PMC article.

4

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.

Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, Feltmate C, Garber JE, Cramer DW, Crum CP. Medeiros F, et al. Among authors: crum cp. Am J Surg Pathol. 2006 Feb;30(2):230-6. doi: 10.1097/01.pas.0000180854.28831.77. Am J Surg Pathol. 2006. PMID: 16434898

5

A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations.

Folkins AK, Jarboe EA, Saleemuddin A, Lee Y, Callahan MJ, Drapkin R, Garber JE, Muto MG, Tworoger S, Crum CP. Folkins AK, et al. Among authors: crum cp. Gynecol Oncol. 2008 May;109(2):168-73. doi: 10.1016/j.ygyno.2008.01.012. Epub 2008 Mar 14. Gynecol Oncol. 2008. PMID: 18342932 Free PMC article.

6

Risk factors for a serous cancer precursor ("p53 signature") in women with inherited BRCA mutations.

Saleemuddin A, Folkins AK, Garrett L, Garber J, Muto MG, Crum CP, Tworoger S. Saleemuddin A, et al. Among authors: crum cp. Gynecol Oncol. 2008 Nov;111(2):226-32. doi: 10.1016/j.ygyno.2008.07.018. Epub 2008 Aug 21. Gynecol Oncol. 2008. PMID: 18718648 Free PMC article.

7

Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations.

Conner JR, Meserve E, Pizer E, Garber J, Roh M, Urban N, Drescher C, Quade BJ, Muto M, Howitt BE, Pearlman MD, Berkowitz RS, Horowitz N, Crum CP, Feltmate C. Conner JR, et al. Among authors: crum cp. Gynecol Oncol. 2014 Feb;132(2):280-6. doi: 10.1016/j.ygyno.2013.12.009. Epub 2013 Dec 12. Gynecol Oncol. 2014. PMID: 24333842 Free PMC article.

8

The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube.

Xian W, Miron A, Roh M, Semmel DR, Yassin Y, Garber J, Oliva E, Goodman A, Mehra K, Berkowitz RS, Crum CP, Quade BJ. Xian W, et al. Among authors: crum cp. J Pathol. 2010 Jan;220(1):17-23. doi: 10.1002/path.2624. J Pathol. 2010. PMID: 19834951 Free PMC article.

9

Cervical cancer screening: from the Papanicolaou smear to the vaccine era.

Crum CP, Abbott DW, Quade BJ. Crum CP, et al. J Clin Oncol. 2003 May 15;21(10 Suppl):224s-230s. doi: 10.1200/JCO.2003.01.116. J Clin Oncol. 2003. PMID: 12743139 Review.

10

Preventing Ovarian Cancer.

Crum CP. Crum CP. J Clin Oncol. 2016 Jan 10;34(2):198-9. doi: 10.1200/JCO.2015.62.9519. Epub 2015 Nov 16. J Clin Oncol. 2016. PMID: 26573077 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

379 results

Search Page